|
1
|
Khare S and Verma M: Epigenetics of colon
cancer. Methods Mol Biol. 863:177–185. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Rajamanickam S and Agarwal R: Natural
products and colon cancer: Current status and future prospects.
Drug Dev Res. 69:460–471. 2008. View Article : Google Scholar
|
|
3
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ambros V: The functions of animal
microRNAs. Nature. 431:350–355. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Baer C, Claus R and Plass C: Genome-wide
epigenetic regulation of miRNAs in cancer. Cancer Res. 73:473–477.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hui AB, Lin A, Xu W, Waldron L,
Perez-Ordonez B, Weinreb I, Shi W, Bruce J, Huang SH, O’Sullivan B,
et al: Potentially prognostic miRNAs in HPV-associated
oropharyngeal carcinoma. Clin Cancer Res. 19:2154–2162. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Yoon KA, Yoon H, Park S, Jang HJ, Zo JI,
Lee HS and Lee JS: The prognostic impact of microRNA sequence
polymorphisms on the recurrence of patients with completely
resected non-small cell lung cancer. J Thorac Cardiovasc Surg.
144:794–807. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhao JJ, Yang J, Lin J, Yao N, Zhu Y,
Zheng J, Xu J, Cheng JQ, Lin JY and Ma X: Identification of miRNAs
associated with tumorigenesis of retinoblastoma by miRNA microarray
analysis. Childs Nerv Syst. 25:13–20. 2009. View Article : Google Scholar
|
|
9
|
Gaedcke J, Grade M, Camps J, Sokilde R,
Kaczkowski B, Schetter AJ, Difilippantonio MJ, Harris CC, Ghadimi
BM, Moller S, et al: The rectal cancer microRNAome - microRNA
expression in rectal cancer and matched normal mucosa. Clin Cancer
Res. 18:4919–4930. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Schultz NA, Werner J, Willenbrock H,
Roslind A, Giese N, Horn T, Wøjdemann M and Johansen JS: MicroRNA
expression profiles associated with pancreatic adenocarcinoma and
ampullary adenocarcinoma. Mod Pathol. 25:1609–1622. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hagedorn EJ, Kelley LC, Naegeli KM, Wang
Z, Chi Q and Sherwood DR: ADF/cofilin promotes invadopodial
membrane recycling during cell invasion in vivo. J Cell Biol.
204:1209–1218. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chen Y, Zhang Z, Yang K, Du J, Xu Y and
Liu S: Myeloid zinc-finger 1 (MZF-1) suppresses prostate tumor
growth through enforcing ferroportin-conducted iron egress.
Oncogene. Oct 6–2014. View Article : Google Scholar : Epub ahead of
print.
|
|
13
|
Boland MJ, Nazor KL and Loring JF:
Epigenetic regulation of pluripotency and differentiation. Circ
Res. 115:311–324. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Takaoka K, Hangaishi A, Ito A, Morioka T,
Kida M and Usuki K: Late hematological improvement of
myelodysplastic syndrome following treatment with 5-azacitidine
therapy. Intern Med. 53:2241–2243. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Daosukho C, Chen Y, Noel T, Sompol P,
Nithipongvanitch R, Velez JM, Oberley TD and St Clair DK:
Phenylbutyrate, a histone deacetylase inhibitor, protects against
adriamycin-induced cardiac injury. Free Radic Biol Med.
42:1818–1825. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Shepelev MV and Korobko IV: Pak6 protein
kinase is a novel effector of an atypical Rho family GTPase
Chp/RhoV. Biochemistry (Mosc). 77:26–32. 2012. View Article : Google Scholar
|
|
17
|
Lee SH, Eom M, Lee SJ, Kim S, Park HJ and
Park D: BetaPix-enhanced p38 activation by
Cdc42/Rac/PAK/MKK3/6-mediated pathway. Implication in the
regulation of membrane ruffling. J Biol Chem. 276:25066–25072.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lee SR, Ramos SM, Ko A, Masiello D,
Swanson KD, Lu ML and Balk SP: AR and ER interaction with a
p21-activated kinase (PAK6). Mol Endocrinol. 16:85–99. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Jaffer ZM and Chernoff J: p21-activated
kinases: Three more join the Pak. Int J Biochem Cell Biol.
34:713–717. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yang F, Li X, Sharma M, Zarnegar M, Lim B
and Sun Z: Androgen receptor specifically interacts with a novel
p21-activated kinase, PAK6. J Biol Chem. 276:15345–15353. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Liu X, Busby J, John C, Wei J, Yuan X and
Lu ML: Direct interaction between AR and PAK6 in
androgen-stimulated PAK6 activation. PLoS One. 8:e773672013.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zapatero A, Morente M, Nieto S, Martín de
Vidales C, Lopez C, Adrados M, Arellano R, Artiga MJ,
Garcia-Vicente F, Herranz LM, et al: Predictive value of PAK6 and
PSMB4 expression in patients with localized prostate cancer treated
with dose-escalation radiation therapy and androgen deprivation
therapy. Urol Oncol. 32:1327–1332. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Chen H, Miao J, Li H, Wang C, Li J, Zhu Y,
Wang J, Wu X and Qiao H: Expression and prognostic significance of
p21-activated kinase 6 in hepatocellular carcinoma. J Surg Res.
189:81–88. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
McCarty SK, Saji M, Zhang X, Jarjoura D,
Fusco A, Vasko VV and Ringel MD: Group I p21-activated kinases
regulate thyroid cancer cell migration and are overexpressed and
activated in thyroid cancer invasion. Endocr Relat Cancer.
17:989–999. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Liu W, Liu H, Liu Y, Xu L, Zhang W, Zhu Y,
Xu J and Gu J: Prognostic significance of p21-activated kinase 6
expression in patients with clear cell renal cell carcinoma. Ann
Surg Oncol. 21:575–583. 2014. View Article : Google Scholar
|
|
26
|
Li H, Zhang B, Liu Y and Yin C: EBP50
inhibits the migration and invasion of human breast cancer cells
via LIMK/cofilin and the PI3K/Akt/mTOR/MMP signaling pathway. Med
Oncol. 31:1622014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Huang X, Sun D, Pan Q, Wen W, Chen Y, Xin
X, Huang M, Ding J and Geng M: JG6, a novel marine-derived
oligosaccha-ride, suppresses breast cancer metastasis via binding
to cofilin. Oncotarget. 5:3568–3578. 2014.PubMed/NCBI
|
|
28
|
Chen P, Zeng M, Zhao Y and Fang X:
Upregulation of Limk1 caused by microRNA-138 loss aggravates the
metastasis of ovarian cancer by activation of Limk1/cofilin
signaling. Oncol Rep. 32:2070–2076. 2014.PubMed/NCBI
|
